Literature DB >> 16259310

A review of myofascial pain and fibromyalgia--factors that promote their persistence.

Robert D Gerwin1.   

Abstract

Chronic muscle pain (myalgia) is a common problem throughout the world. Seemingly simple, it is actually a difficult problem for the clinician interested in determining the aetiology of the pain, as well as in managing the pain. The two common muscle pain conditions are fibromyalgia and myofascial pain syndrome. Fibromyalgia is a chronic, widespread muscle tenderness syndrome, associated with central sensitisation. It is often accompanied by chronic sleep disturbance and fatigue, visceral pain syndromes like irritable bowel syndrome and interstitial cystitis. Myofascial pain syndrome is an overuse or muscle stress syndrome characterised by the presence of trigger points in muscle. The problem these syndromes pose lies not in making the diagnosis of muscle pain. Rather, it is the need to identify the underlying cause(s) of persistent or chronic muscle pain in order to develop a specific treatment plan. Chronic myalgia may not improve until the underlying precipitating or perpetuating factor(s) are themselves managed. Precipitating or perpetuating causes of chronic myalgia include structural or mechanical causes like scoliosis, localised joint hypomobility, or generalised or local joint laxity; and metabolic factors like depleted tissue iron stores, hypothyroidism or Vitamin D deficiency. Sometimes, correction of an underlying cause of myalgia is all that is needed to resolve the condition.

Entities:  

Mesh:

Year:  2005        PMID: 16259310     DOI: 10.1136/aim.23.3.121

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  24 in total

1.  DRY NEEDLING FOR MYOFASCIAL TRIGGER POINT PAIN: A CLINICAL COMMENTARY.

Authors:  Casey Unverzagt; Kathy Berglund; J J Thomas
Journal:  Int J Sports Phys Ther       Date:  2015-06

2.  A randomized, placebo-controlled double-blinded comparative clinical study of five over-the-counter non-pharmacological topical analgesics for myofascial pain: single session findings.

Authors:  Daniel Avrahami; Amanda Hammond; Ceara Higgins; Howard Vernon
Journal:  Chiropr Man Therap       Date:  2012-03-21

3.  Effect of high-intensity laser therapy in the management of myofascial pain syndrome of the trapezius: a double-blind, placebo-controlled study.

Authors:  Umit Dundar; Utku Turkmen; Hasan Toktas; Ozlem Solak; Alper Murat Ulasli
Journal:  Lasers Med Sci       Date:  2014-10-02       Impact factor: 3.161

Review 4.  Effect of treatment on trigger points.

Authors:  Javid Majlesi; Halil Unalan
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 5.  New trends in the treatment and management of myofascial pain syndrome.

Authors:  John Z Srbely
Journal:  Curr Pain Headache Rep       Date:  2010-10

6.  Effect of stress on the expression of rho-kinase and collagen in rat bladder tissue.

Authors:  Hana Yoon; Donghyun Lee; Kyemin Chun; Hyunsuk Yoon; Jaeyeong Yoo
Journal:  Korean J Urol       Date:  2010-02-18

7.  Comorbidity of fibromyalgia and cervical myofascial pain syndrome.

Authors:  Burcu Duyur Cakit; Suhan Taskin; Baris Nacir; Irem Unlu; Hakan Genc; Hatice Rana Erdem
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

Review 8.  Myofascial low back pain.

Authors:  Ryan R Ramsook; Gerard A Malanga
Journal:  Curr Pain Headache Rep       Date:  2012-10

9.  Myofascial trigger points in cluster headache patients: a case series.

Authors:  Elena P Calandre; Javier Hidalgo; Juan M Garcia-Leiva; Fernando Rico-Villademoros; Antonia Delgado-Rodriguez
Journal:  Head Face Med       Date:  2008-12-30       Impact factor: 2.151

10.  Contributions of myofascial pain in diagnosis and treatment of shoulder pain. A randomized control trial.

Authors:  Sara Perez-Palomares; Bárbara Oliván-Blázquez; Ana M Arnal-Burró; Orlando Mayoral-Del Moral; Elena Gaspar-Calvo; M Luisa de-la-Torre-Beldarraín; Elena López-Lapeña; Marina Pérez-Benito; Victoria Ara-Loriente; Laura Romo-Calvo
Journal:  BMC Musculoskelet Disord       Date:  2009-07-24       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.